Childhood vaccinations, immunization schedules and vaccine safety, helping parents understand recommended vaccines and make informed decisions for their children.
In northern Nigeria, traditional leaders play a pivotal role in restoring trust and increasing immunisation rates amid persistent challenges of insecurity, misinformation, and coverage gaps. In northern Nigeria, public health workers are leaning on an old but powerful tool: trust.…
The UK Health Security Agency has intensified efforts to boost measles vaccination rates amid recent outbreaks and concerns over vaccine coverage gaps among at-risk populations. The UK Health Security Agency is urging families to check whether they are protected against…
The CDC reports a surge of 94 new measles infections across the US, indicating a potential return to endemic levels and jeopardising the country’s measles elimination status for the first time in over two decades. The Centres for Disease Control…
Studies from Belgium, Spain, and the United States highlight that vaccine failures in young children are uncommon but linked to specific serotypes, underscoring the need for ongoing surveillance as newer vaccine formulations are introduced. Pneumococcal vaccine failure in young children…
New phase 3 trial data bolster Merck’s clesrovimab as a promising option to protect children under 2 at high risk of severe respiratory syncytial virus (RSV) illness entering their second season, with FDA review underway for expanded approval. Merck said…
A recent review highlights the importance of routine vaccination and prompt antiviral treatment in reducing severe outcomes of varicella-zoster virus in children, especially newborns and high-risk groups. A March 2025 narrative review in the Indian Journal of Paediatric Dermatology says…
The European Commission has expanded Bavarian Nordic’s Imvanex vaccine approval to include children from 2 years old, enhancing protection amid a severe mpox outbreak affecting vulnerable populations in Africa and Europe. The European Commission has expanded Bavarian Nordic’s Imvanex vaccine…
Researchers in Southampton have made progress toward a vaccine that remains effective under less demanding storage conditions, potentially transforming immunisation efforts in re Researchers in Southampton say they have taken a step towards a vaccine that can survive far less…
The US FDA is reviewing a request from Merck to extend the use of Enflonsia, potentially extending protection for children under 2 after their first respiratory syncytial virus (RSV) season, amid growing concerns over repeat infections. The US Food and…
Traditional leaders in northern Nigeria are increasingly vital in bridging mistrust and boosting vaccination coverage amid persistent poliovirus cases, as health officials intensify community engagement and seek additional funding for immunisation programmes. Traditional leaders in northern Nigeria are being cast…
The European Commission has authorised the use of Bavarian Nordic’s Imvanex vaccine for children aged 2 to under 12, marking a significant advancement in protective measures against mpox and smallpox across the EU amid ongoing public health concerns. Bavarian Nordic…
Sanofi’s MenQuadfi now approved for infants as young as 6 weeks in the EU, offering earlier protection against invasive meningococcal disease and its serious complications, including hearing loss. The European Commission has cleared Sanofi’s MenQuadfi vaccine for use in infants…
